• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Porcine acute liver failure model established by two-phase surgery and treated with hollow fiber bioartificial liver support system.通过两阶段手术建立并采用中空纤维生物人工肝支持系统治疗的猪急性肝衰竭模型。
World J Gastroenterol. 2005 Sep 21;11(35):5468-74. doi: 10.3748/wjg.v11.i35.5468.
2
Experimental research on TECA-I bioartificial liver support system to treat canines with acute liver failure.TECA-I生物人工肝支持系统治疗犬急性肝衰竭的实验研究
World J Gastroenterol. 2001 Oct;7(5):706-9. doi: 10.3748/wjg.v7.i5.706.
3
Functional evaluation of a new bioartificial liver system in vitro and in vitro.一种新型生物人工肝系统的体内和体外功能评估。 需注意,原文中“in vitro and in vitro”表述有误,推测可能是“in vivo and in vitro”(体内和体外),按照正确内容进行了翻译。
World J Gastroenterol. 2006 Feb 28;12(8):1312-6. doi: 10.3748/wjg.v12.i8.1857.
4
Bioartificial liver inoculated with porcine hepatocyte spheroids for treatment of canine acute liver failure model.接种猪肝细胞球状体的生物人工肝用于治疗犬急性肝衰竭模型。
Artif Organs. 2003 Jul;27(7):613-22. doi: 10.1046/j.1525-1594.2003.07140.x.
5
In vitro safety and efficacy evaluation of a novel hybrid bioartificial liver system with simulated liver failure serum.新型混合生物人工肝系统在模拟肝衰竭血清中的体外安全性和有效性评估。
Int J Artif Organs. 2022 May;45(5):523-532. doi: 10.1177/03913988221091286. Epub 2022 Apr 13.
6
Functional Evaluation of a Bioartificial Liver Support System Using Immobilized Hepatocyte Spheroids in a Porcine Model of Acute Liver Failure.应用固定化肝细胞球体制备生物人工肝支持系统在猪急性肝衰竭模型中的功能评价。
Sci Rep. 2017 Jun 19;7(1):3804. doi: 10.1038/s41598-017-03424-2.
7
Artificial liver support in pigs with acetaminophen-induced acute liver failure.对乙酰氨基酚诱导的猪急性肝衰竭的人工肝支持
World J Gastroenterol. 2017 May 14;23(18):3262-3268. doi: 10.3748/wjg.v23.i18.3262.
8
Human fetal hepatocyte line, L-02, exhibits good liver function in vitro and in an acute liver failure model.人胎儿肝细胞系L-02在体外及急性肝衰竭模型中均表现出良好的肝功能。
Transplant Proc. 2013 Mar;45(2):695-700. doi: 10.1016/j.transproceed.2012.09.121.
9
Bioartificial liver support system using porcine hepatocytes entrapped in a three-dimensional hollow fiber module with collagen gel: An evaluation in the swine acute liver failure model.
Artif Organs. 1999 Sep;23(9):822-8. doi: 10.1046/j.1525-1594.1999.06323.x.
10
Devascularization surgical model of acute liver failure in minipigs.小型猪急性肝衰竭去血管化手术模型
Eur Surg Res. 2004 May-Jun;36(3):179-84. doi: 10.1159/000077261.

引用本文的文献

1
The multifaceted role of macrophages during acute liver injury.巨噬细胞在急性肝损伤中的多效性作用。
Front Immunol. 2023 Sep 6;14:1237042. doi: 10.3389/fimmu.2023.1237042. eCollection 2023.
2
Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure.纳米生物材料在急性肝衰竭治疗与成像中的应用
Nanomicro Lett. 2020 Nov 19;13(1):25. doi: 10.1007/s40820-020-00550-x.
3
Establishment of a Novel Simplified Surgical Model of Acute Liver Failure in the Cynomolgus Monkey.建立一种新型简化的食蟹猴急性肝衰竭手术模型。
Biomed Res Int. 2016;2016:3518989. doi: 10.1155/2016/3518989. Epub 2016 Dec 21.
4
Dynamic tracking of stem cells in an acute liver failure model.在急性肝衰竭模型中对干细胞进行动态跟踪。
World J Gastroenterol. 2012 Feb 14;18(6):507-16. doi: 10.3748/wjg.v18.i6.507.
5
An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure.用于研究急性肝衰竭发病机制及治疗策略的动物模型概述。
World J Gastroenterol. 2009 Jul 7;15(25):3086-98. doi: 10.3748/wjg.15.3086.

本文引用的文献

1
Devascularization surgical model of acute liver failure in minipigs.小型猪急性肝衰竭去血管化手术模型
Eur Surg Res. 2004 May-Jun;36(3):179-84. doi: 10.1159/000077261.
2
Microcapsules with improved mechanical stability for hepatocyte culture.用于肝细胞培养的具有改善的机械稳定性的微胶囊。
Biomaterials. 2003 May;24(10):1771-80. doi: 10.1016/s0142-9612(02)00580-x.
3
[Isolation and culture of pig hepatocyte in large scale for the application of bioartificial liver system].[用于生物人工肝系统的猪肝细胞大规模分离与培养]
Taehan Kan Hakhoe Chi. 2002 Sep;8(3):249-55.
4
Successful pregnancy after porcine bioartificial liver treatment and liver transplantation for fulminant hepatic failure.
Liver Transpl. 2002 Feb;8(2):169-70. doi: 10.1053/jlts.2002.30593.
5
Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems.会是哪种肝细胞呢?生物人工肝支持系统的肝细胞选择。
Liver Transpl. 2001 Jan;7(1):2-10. doi: 10.1053/jlts.2001.20845.
6
Bioartificial liver in the treatment of hepatic failure.
Liver Transpl. 2000 Jul;6(4 Suppl 1):S27-30. doi: 10.1002/lt.500060507.
7
Oxygen transfer in a diffusion-limited hollow fiber bioartificial liver.扩散限制型中空纤维生物人工肝中的氧传递
Artif Organs. 2000 Apr;24(4):278-88. doi: 10.1046/j.1525-1594.2000.06499.x.
8
Cultivation of immortalized human hepatocytes HepZ on macroporous CultiSpher G microcarriers.永生化人肝细胞HepZ在大孔CultiSpher G微载体上的培养。
Biotechnol Bioeng. 2000 Apr 5;68(1):59-70. doi: 10.1002/(sici)1097-0290(20000405)68:1<59::aid-bit7>3.0.co;2-n.
9
Bioartificial liver support system using porcine hepatocytes entrapped in a three-dimensional hollow fiber module with collagen gel: An evaluation in the swine acute liver failure model.
Artif Organs. 1999 Sep;23(9):822-8. doi: 10.1046/j.1525-1594.1999.06323.x.
10
Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors.暴发性肝衰竭大鼠的生物人工肝治疗:对肝脏富集和生长相关转录因子DNA结合活性的影响
J Surg Res. 1999 Aug;85(2):243-50. doi: 10.1006/jsre.1999.5669.

通过两阶段手术建立并采用中空纤维生物人工肝支持系统治疗的猪急性肝衰竭模型。

Porcine acute liver failure model established by two-phase surgery and treated with hollow fiber bioartificial liver support system.

作者信息

Gao Yi, Mu Ning, Xu Xiao-Ping, Wang Yan

机构信息

Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong Province, China.

出版信息

World J Gastroenterol. 2005 Sep 21;11(35):5468-74. doi: 10.3748/wjg.v11.i35.5468.

DOI:10.3748/wjg.v11.i35.5468
PMID:16222738
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4320355/
Abstract

AIM

To establish a highly reproducible animal model of acute liver failure (ALF), for assessing the effect of bioartificial liver support system (BALSS).

METHODS

A two-phase complete liver devascularization procedure was performed in eight loco-hybrid pigs. Blood biochemical index and liver biopsy were studied every 2 h after surgery, and survival time was recorded. The BALSS constructed with high volume recirculating technique was a hollow fiber circulating system consisting of a hepatocyte reactor-hollow fiber module inoculated with microcarrier-adhering hepatocytes, and a double pump, heparinized, thermostabilized, micro-capsulized activated carbon-adsorbing plasmapheresis system. Twelve pigs undergoing two-phase surgery were randomized into: control group (perfused without hepatocytes, n = 6) and treatment group (perfused with hepatocytes, n = 6). Intergroup liver biochemical indexes, survival time, and liver pathological changes were analyzed at regular intervals.

RESULTS

Two-phase surgery was performed in all the experimental pigs, and there was no obvious difference between their biochemical indexes. After 3 h of phase II surgery, ammonia (Amm) increased to (269+/-37) micromol/L. After 5 h of the surgery, fibrinogen (Fib) decreased to (1.5+/-0.2) g/L. After 7 h of the surgery, ALT, AST, Tbil and PT were (7.6+/-1.8) nka/L, (40+/-5) nka/L, (55+/-8) micromol/L and (17.5+/-1.7) nka/L respectively. After 9 h of surgery, ALB and Cr were (27+/-4) g/L and (87+/-9) micromol/L. After 13 h of surgery, BUN was (3.5+/-0.9) micromol/L. All the above values were different from those determined before surgery. Survival time of pigs averaged 13.5+/-1.4 h. ALF pigs in the other group were treated with BALSS. The comparison analysis between the treated and control animals showed the changes of Tbil, PT, Alb, BUN, Cr, Fib, and Amm (P<0.01), but there was no change of ALT and AST. The survival time was statistically different (P<0.01), and there was no significant difference in histological changes.

CONCLUSION

The porcine ALF model established by two-phase devascularized surgery is valid and reproducible. The hollow fiber BALSS can meet the needs of life support and is effective in treating ALF.

摘要

目的

建立一种高度可重复的急性肝衰竭(ALF)动物模型,用于评估生物人工肝支持系统(BALSS)的效果。

方法

对8只本地杂交猪进行两阶段完全肝去血管化手术。术后每2小时研究血液生化指标和肝活检,并记录存活时间。采用大容量循环技术构建的BALSS是一种中空纤维循环系统,由接种微载体黏附肝细胞的肝细胞反应器 - 中空纤维模块和双泵、肝素化、热稳定、微囊化活性炭吸附血浆置换系统组成。12只接受两阶段手术的猪被随机分为:对照组(未灌注肝细胞,n = 6)和治疗组(灌注肝细胞,n = 6)。定期分析组间肝生化指标、存活时间和肝病理变化。

结果

所有实验猪均进行了两阶段手术,其生化指标之间无明显差异。第二阶段手术后3小时,氨(Amm)升至(269±37)微摩尔/升。手术后5小时,纤维蛋白原(Fib)降至(1.5±0.2)克/升。手术后7小时,谷丙转氨酶(ALT)、谷草转氨酶(AST)、总胆红素(Tbil)和凝血酶原时间(PT)分别为(7.6±1.8)纳卡/升、(40±5)纳卡/升、(55±8)微摩尔/升和(17.5±1.7)纳卡/升。手术后9小时,白蛋白(ALB)和肌酐(Cr)分别为(27±4)克/升和(87±9)微摩尔/升。手术后13小时,尿素氮(BUN)为(3.5±0.9)微摩尔/升。上述所有值均与手术前测定的值不同。猪的平均存活时间为13.5±1.4小时。另一组的ALF猪用BALSS治疗。治疗组与对照组动物的比较分析显示Tbil、PT、Alb、BUN、Cr、Fib和Amm有变化(P<0.01),但ALT和AST无变化。存活时间有统计学差异(P<0.01),组织学变化无显著差异。

结论

通过两阶段去血管化手术建立的猪ALF模型有效且可重复。中空纤维BALSS能够满足生命支持需求,对治疗ALF有效。